Table 3.
Acute effects of OSE and CSE on blood levels of BDNFP, BDNFS, IGF-1 and IL-6
| Variable | Intervention group | CG | ||||
|---|---|---|---|---|---|---|
| aOSE | aCSE | |||||
| Pre | Post | Pre | Post | Pre | Post | |
| BDNFP (pg/ml) | 1599.54 (738.57) | 1804.63* (780.00) | 1376.26 (621.73) | 1682.04# (807.15) | 1825.43 (927.54) | 1950.14 (1043.07) |
| BDNFS (pg/ml) | 27,525.00 (6781.45) | 29,783.33** (7433.40) | 26,473.91 (6317.31) | 29,556.52** (6929.83) | 27,685.71 (7380.52) | 27,528.57 (6848.74) |
| IGF-1 (ng/ml) | 183.33 (66.83) | 192.13** (65.65) | 192.42 (70.50) | 201.29** (75.30) | 174.50 (63.66) | 174.00 (64.94) |
| IL-6 (ng/L) | 2.15 (1.65) | 3.25* (2.90) | 1.60 (1.18) | 2.75** (2.88) | 1.55 (0.53) | 1.60 (0.60) |
Mean values (standard deviation) of BDNFP, BDNFS, and serum IGF-1—as well as median values (interquartile range) of serum IL-6 at pre-test and post-test
For BDNFP, BDNFS, and IGF-1, parametric tests were used. For IL-6, non-parametric tests were used
BDNF brain-derived neurotrophic factor; IGF-1 insulin-like growth factor 1; IL-6 interleukine-6
Asterisk indicate significant difference between pre-test and post-test (*0.050 > p ≥ 00.001; **p < 0.001)
Number sign indicate a tendency for difference between pre-test and post-test (#0.100 > p ≥ 0.050)